Europe Neurostimulation Devices Market to 2030 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Europe Neurostimulation Devices Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. Europe Neurostimulation Devices Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Rising cases of neurological disorders
5.1.2 Demand for non-invasive treatment options

5.2 Market Opportunities

5.2.1 Growth in pain management applications
5.2.2 Expansion of neurostimulation in mental health treatment

5.3 Future Trends

5.3.1 Advances in wireless neurostimulation devices
5.3.2 Integration with wearable health technologies

5.4 Impact of Drivers and Restraints

6. Europe Neurostimulation Devices Market Regional Analysis

6.1 Europe Neurostimulation Devices Market Overview

6.2 Europe Neurostimulation Devices Market Revenue 2020-2030 (US$ Million)

6.3 Europe Neurostimulation Devices Market Forecast Analysis

7. Europe Neurostimulation Devices Market Analysis – by Product

7.1 Spinal Cord Stimulator

7.1.1 Overview
7.1.2 Spinal Cord Stimulator: Europe Neurostimulation Devices Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Deep Brain Stimulator

7.2.1 Overview
7.2.2 Deep Brain Stimulator: Europe Neurostimulation Devices Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Sacral Nerve Stimulator

7.3.1 Overview
7.3.2 Sacral Nerve Stimulator: Europe Neurostimulation Devices Market – Revenue and Forecast to 2031 (US$ Million)

7.4 Vagus Nerve Stimulator

7.4.1 Overview
7.4.2 Vagus Nerve Stimulator: Europe Neurostimulation Devices Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe Neurostimulation Devices Market Analysis – by Application

8.1 Pain Management

8.1.1 Overview
8.1.2 Pain Management: Europe Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)

8.2 Epilepsy

8.2.1 Overview
8.2.2 Epilepsy: Europe Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)

8.3 Urinary and Fecal Incontinence

8.3.1 Overview
8.3.2 Urinary and Fecal Incontinence: Europe Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)

8.4 Parkinson\'s Disease

8.4.1 Overview
8.4.2 Parkinson\'s Disease: Europe Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)

9. Europe Neurostimulation Devices Market Analysis – by End User

9.1 Hospitals

9.1.1 Overview
9.1.2 Parkinson\'s Disease: Europe Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)

9.2 Specialty Clinics

9.2.1 Overview
9.2.2 Parkinson\'s Disease: Europe Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)

10. Europe Neurostimulation Devices Market – Europe Analysis

10.1 Europe

10.1.1 Europe Neurostimulation Devices Market Breakdown, by Key Country, 2023 and 2030 (%)
10.1.1.1 Europe Neurostimulation Devices Market – Revenue and Forecast Analysis – by Country
10.1.1.1 UK: Europe Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.1 UK: Europe Neurostimulation Devices Market Breakdown, by Product
10.1.1.1.2 UK: Europe Neurostimulation Devices Market Breakdown, by Application
10.1.1.1.3 UK: Europe Neurostimulation Devices Market Breakdown, by End User

10.1.1.2 Germany: Europe Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.1 Germany: Europe Neurostimulation Devices Market Breakdown, by Product
10.1.1.2.2 Germany: Europe Neurostimulation Devices Market Breakdown, by Application
10.1.1.2.3 Germany: Europe Neurostimulation Devices Market Breakdown, by End User

10.1.1.3 France: Europe Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.1 France: Europe Neurostimulation Devices Market Breakdown, by Product
10.1.1.3.2 France: Europe Neurostimulation Devices Market Breakdown, by Application
10.1.1.3.3 France: Europe Neurostimulation Devices Market Breakdown, by End User

10.1.1.4 Russia: Europe Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.4.1 Russia: Europe Neurostimulation Devices Market Breakdown, by Product
10.1.1.4.2 Russia: Europe Neurostimulation Devices Market Breakdown, by Application
10.1.1.4.3 Russia: Europe Neurostimulation Devices Market Breakdown, by End User

10.1.1.5 Italy: Europe Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.5.1 Italy: Europe Neurostimulation Devices Market Breakdown, by Product
10.1.1.5.2 Italy: Europe Neurostimulation Devices Market Breakdown, by Application
10.1.1.5.3 Italy: Europe Neurostimulation Devices Market Breakdown, by End User

10.1.1.6 Rest of Europe: Europe Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.6.1 Rest of Europe: Europe Neurostimulation Devices Market Breakdown, by Product
10.1.1.6.2 Rest of Europe: Europe Neurostimulation Devices Market Breakdown, by Application
10.1.1.6.3 Rest of Europe: Europe Neurostimulation Devices Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Europe Neurostimulation Devices Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Medtronic Plc

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Boston Scientific Corp

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Abbott Laboratories

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Nevro Corp

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 LivaNova Plc

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Synapse Biomedical Inc

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 ElectroCore Inc

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Mainstay Medical

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

14. Appendix

14.1 About Business Market Insights